157 related articles for article (PubMed ID: 33203828)
21. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
[TBL] [Abstract][Full Text] [Related]
22. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.
Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805
[TBL] [Abstract][Full Text] [Related]
23. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model.
Nozaki Y; Fujita K; Wada K; Yoneda M; Kessoku T; Shinohara Y; Imajo K; Ogawa Y; Nakamuta M; Saito S; Masaki N; Nagashima Y; Terauchi Y; Nakajima A
BMC Gastroenterol; 2015 Apr; 15():42. PubMed ID: 25881230
[TBL] [Abstract][Full Text] [Related]
25. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression.
Qin G; Wang GZ; Guo DD; Bai RX; Wang M; Du SY
J Dig Dis; 2018 May; 19(5):301-313. PubMed ID: 29696816
[TBL] [Abstract][Full Text] [Related]
26.
Zhang YH; Ma Q; Ding P; Li J; Chen LL; Ao KJ; Tian YY
Yonsei Med J; 2018 Nov; 59(9):1064-1071. PubMed ID: 30328321
[TBL] [Abstract][Full Text] [Related]
27. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease.
Li G; Zhang J; Jiang Q; Liu B; Xu K
Life Sci; 2020 Aug; 254():117795. PubMed ID: 32417373
[TBL] [Abstract][Full Text] [Related]
28. Alpha-syntrophin null mice are protected from non-alcoholic steatohepatitis in the methionine-choline-deficient diet model but not the atherogenic diet model.
Rein-Fischboeck L; Haberl EM; Pohl R; Schmid V; Feder S; Krautbauer S; Liebisch G; Buechler C
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 May; 1863(5):526-537. PubMed ID: 29474931
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin B deficiency ameliorates liver lipid deposition, inflammatory cell infiltration, and fibrosis after diet-induced nonalcoholic steatohepatitis.
Fang W; Deng Z; Benadjaoud F; Yang C; Shi GP
Transl Res; 2020 Aug; 222():28-40. PubMed ID: 32434697
[TBL] [Abstract][Full Text] [Related]
30. CD11c+ resident macrophages drive hepatocyte death-triggered liver fibrosis in a murine model of nonalcoholic steatohepatitis.
Itoh M; Suganami T; Kato H; Kanai S; Shirakawa I; Sakai T; Goto T; Asakawa M; Hidaka I; Sakugawa H; Ohnishi K; Komohara Y; Asano K; Sakaida I; Tanaka M; Ogawa Y
JCI Insight; 2017 Nov; 2(22):. PubMed ID: 29202448
[TBL] [Abstract][Full Text] [Related]
31. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin I
Kumei S; Yuhki KI; Kojima F; Kashiwagi H; Imamichi Y; Okumura T; Narumiya S; Ushikubi F
FASEB J; 2018 May; 32(5):2354-2365. PubMed ID: 29247122
[TBL] [Abstract][Full Text] [Related]
33. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
34. A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8
Muñoz-Durango N; Arrese M; Hernández A; Jara E; Kalergis AM; Cabrera D
Front Immunol; 2020; 11():563434. PubMed ID: 33391254
[TBL] [Abstract][Full Text] [Related]
35. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
37. Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis.
Pizarro M; Solís N; Quintero P; Barrera F; Cabrera D; Rojas-de Santiago P; Arab JP; Padilla O; Roa JC; Moshage H; Wree A; Inzaugarat E; Feldstein AE; Fardella CE; Baudrand R; Riquelme A; Arrese M
Liver Int; 2015 Sep; 35(9):2129-38. PubMed ID: 25646700
[TBL] [Abstract][Full Text] [Related]
38. Raloxifene Ameliorates Liver Fibrosis of Nonalcoholic Steatohepatitis Induced by Choline-Deficient High-Fat Diet in Ovariectomized Mice.
Luo F; Ishigami M; Achiwa K; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Ishikawa T; Katano Y; Goto H
Dig Dis Sci; 2015 Sep; 60(9):2730-9. PubMed ID: 25868633
[TBL] [Abstract][Full Text] [Related]
39. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
40. Galectin-3 and IL-33/ST2 axis roles and interplay in diet-induced steatohepatitis.
Pejnovic N; Jeftic I; Jovicic N; Arsenijevic N; Lukic ML
World J Gastroenterol; 2016 Nov; 22(44):9706-9717. PubMed ID: 27956794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
